Vimarsana
Biggest News Aggregation in the World

Page 3 - Code Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Code Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Code Therapeutics Today - Breaking & Trending Today

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer - Vimarsana News

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. RNAZ, the RNA oncology company committed to more effectively treating cancer using RNA…

Source: biztoc.com
ReCode Therapeutics to Participate in February Conferences - Vimarsana News

ReCode Therapeutics to Participate in February Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--Feb 20, 2024--

Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders' Equity Requirement and Continued Listing on The Nasdaq Stock Market Seite 1 - Vimarsana News

Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders' Equity Requirement and Continued Listing on The Nasdaq Stock Market Seite 1

31.01.2024 - BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from ... Seite 1

TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid ... - Vimarsana News

TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid ...

BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced a co-research agreement

Reviewing Verve Therapeutics (NASDAQ:VERV) and TransCode Therapeutics (NASDAQ:RNAZ) - Vimarsana News

Reviewing Verve Therapeutics (NASDAQ:VERV) and TransCode Therapeutics (NASDAQ:RNAZ)

Verve Therapeutics (NASDAQ:VERV – Get Free Report) and TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Verve […]

Source: wkrb13.com